OLARIS
Olaris is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging our CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, we harness the power of the body’s own communication system to discover and develop our pipeline of myOLARIS™ precision diagnostics. To learn more, visit https://www.myolaris.com/ The company was founded in 2013 and is headquartered in Framingham, Massachusetts.
OLARIS
Industry:
Biopharma Biotechnology Health Care Health Diagnostics
Founded:
2013-06-01
Address:
Framingham, Massachusetts, United States
Country:
United States
Website Url:
http://www.myolaris.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google Google Cloud Microsoft Microsoft Azure Wix
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Current Employees Featured
Founder
Investors List
Alumni Ventures
Alumni Ventures investment in Series B - Olaris
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Olaris
Alumni Ventures
Alumni Ventures investment in Series A - Olaris
Innospark Ventures
Innospark Ventures investment in Venture Round - Olaris
Official Site Inspections
http://www.myolaris.com Semrush global rank: 2 M Semrush visits lastest month: 10.67 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Olaris"
CAREERS - Olaris, Inc
Does working in a start-up pioneering a new way to treat and diagnose disease get you excited? Does the idea of working on diverse projects in a fast-paced, dynamic organization get your …See details»
Team (All) - Olaris, Inc
Dr. Elizabeth O'Day is the CEO and Founder of Olaris, Inc., a precision medicine company that uses a pioneering metabolomics platform and proprietary machine learning algorithms to …See details»
Olaris - Crunchbase Company Profile & Funding
Contact Email [email protected] Olaris is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging our CEREBRO platform (Comprehensive Early …See details»
Olaris, Inc - LinkedIn
Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, which aim to optimize …See details»
Company Information - RocketReach
Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, which aim to optimize …See details»
Olaris Company Profile - Office Locations, Competitors, Revenue
Olaris is a precision medicine company that specializes in the development of diagnostics products. It offers in-vitro diagnostics (IVDs) to enable response monitoring, treatment …See details»
Olaris - CoBee Company Profile & Funding Rounds
Olaris is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging our CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to …See details»
Olaris, Inc to present non-invasive metabolic signature to ... - PRWeb
FRAMINGHAM, Mass., May 12, 2022 /PRNewswire-PRWeb/ -- Olaris, Inc, a precision medicine company leveraging metabolomics and machine learning for the discovery and development …See details»
WHO WE ARE - Olaris, Inc
Olaris is revolutionizing how diseases are diagnosed and treated by combining metabolomics and machine learning to develop precision diagnostics for the entire patient journey.See details»
Olaris - Products, Competitors, Financials, Employees, …
Myolaris.com. Overview & Products; Financials; People; Founded Year 2014. Stage Series B | Alive. Total Raised $4.2M. About Olaris. Olaris is a precision medicine company focused on …See details»
Olaris - Work in biotech
Olaris is developing new in vitro diagnostic tools by using metabolomics and machine learning. Olaris recognized the issue of “imprecision medicine”, in which many drugs are not effective …See details»
Olaris - Overview, News & Similar companies | ZoomInfo.com
Mar 28, 2022 Olaris contact info: Phone number: (617) 823-9858 Website: www.myolaris.com What does Olaris do? Founded in 2014, Olaris a precision medicine company that uses a …See details»
Olaris - Company Profile - Tracxn
Nov 28, 2024 Olaris - Developer of in-vitro diagnostics for oncology, solid-organ transplant, and neurodegeneration. Raised a total funding of $62.5K over 3 rounds from 5 investors. Founded …See details»
Olaris Company Profile: Funding, Investors & Partnerships
Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, which aim to optimize …See details»
CONTACT - Olaris, Inc
Using a proprietary metabolite profiling platform and customized machine learning algorithms, Olaris can identify individual molecular profiles so detailed that the guess work in how to treat …See details»
Olaris, Inc. (@myolaris) • Instagram photos and videos
64 Followers, 225 Following, 107 Posts - Olaris, Inc. (@myolaris) on Instagram: "Leveraging metabolomics and machine learning through our myOLARIS™ diagnostics products. Our …See details»
Elizabeth O'Day - Olaris, Inc
Dr. Elizabeth O'Day has over a decade of experience in metabolomics, biochemistry, and precision medicine. She is the CEO and Founder of Olaris, Inc., a precision medicine company …See details»
Olaris Presents myOLARIS-KTdx at ATC 2022 - YouTube
Presentation of Olaris' study on the application of its myOLARIS-KTdx kidney transplant graft status score to transplant recipients with stable grafts, polyo...See details»
PRESS RELEASES - Olaris, Inc
Jun 6, 2022 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning to discover and develop its myOLARIS™ diagnostics products, is pleased to …See details»